An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
Completed
- Conditions
- Spondylitis, AnkylosingArthritis, RheumatoidPsoriasisArthritis, Psoriatic
- Interventions
- Drug: Infliximab; observational studyDrug: Methotrexate; observational study
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2013-10-29
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1061
- Registration Number
- NCT00760669
Post Marketing Surveillance of Remicade
Completed
- Conditions
- Crohn's DiseaseAnkylosing Spondylitis
- Interventions
- Biological: Infliximab
- First Posted Date
- 2008-07-29
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 938
- Registration Number
- NCT00724529
A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets
Completed
- Conditions
- Rheumatic Diseases
- Interventions
- Drug: Tramadol/acetaminophen
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 982
- Registration Number
- NCT00642837
A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy
Phase 4
Completed
- Conditions
- Diabetic Neuropathy
- Interventions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 162
- Registration Number
- NCT00634543
A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee Osteoarthritis
Phase 4
Completed
- Conditions
- Osteoarthritis
- Interventions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2013-07-22
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 143
- Registration Number
- NCT00635349
An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 345
- Registration Number
- NCT00613327
Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1142
- Registration Number
- NCT00614536
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
Completed
- Conditions
- SchizophreniaTherapeutic UsesPhysiological Effects of DrugsPsychotropic DrugsTranquilizing AgentsMental DisordersAntipsychotic Agents
- Interventions
- First Posted Date
- 2006-02-20
- Last Posted Date
- 2014-04-03
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 230
- Registration Number
- NCT00294008
A Study of the Prevalence of Headache in Epileptic Patients
Completed
- Conditions
- Epilepsy
- Interventions
- Other: A structured questionnaire for seizure-related headache
- First Posted Date
- 2006-01-16
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 719
- Registration Number
- NCT00277368
An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia
Phase 4
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2014-04-16
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 40
- Registration Number
- NCT00269919
© Copyright 2025. All Rights Reserved by MedPath